Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery

Claes Held,Nils Åsenblad,Jean Pierre Bassand,Richard C. Becker,Christopher P. Cannon,Marc J. Claeys,Robert A. Harrington,Jay Horrow,Steen Husted,Stefan K. James,Kenneth W. Mahaffey,José C. Nicolau,Benjamin M. Scirica,Robert F. Storey,Marius Vintila,Joseph Ycas,Lars Wallentin

Journal of the American College of Cardiology（2011）

引用 477|浏览22

暂无评分

摘要

Conclusions In the subgroup of patients undergoing CABG within 7 days after the last study drug intake, ticagrelor compared with clopidogrel was associated with a substantial reduction in total and CV mortality without excess risk of CABG-related bleeding.

查看译文

关键词

acute coronary syndromes,clopidogrel,coronary artery bypass grafting,ticagrelor

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要